No long-term effects of hormonal therapy preceding brachytherapy on urinary function and health-related quality of life among prostate cancer patients

Urology

Volumn 76, Issue 5, 2010, Pages 1150-1156

  Evers, Judith ^a   Kupper, Nina ^a,b   Kessing, Dionne ^b   Davits, Rob ^a   Engelen, Antoine ^b   Poortmans, Philip ^c   Mols, Floortje ^b  

^a Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c Institute Verbeeten   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BICALUTAMIDE; GONADORELIN AGONIST; IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; EMOTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; URINARY DYSFUNCTION;

AGED; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; GONADOTROPIN-RELEASING HORMONE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NITRILES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; TOSYL COMPOUNDS; URINATION;

EID: 78149360466     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.02.051     Document Type: Article

References (30)

1. D. Ash, D. Bottomley, B. Al-Qaisieh, B. Carey, K. Gould, and A. Henry A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer Radiother Oncol. 84 2007 135 139
2. M.G. Sanda, R.L. Dunn, J. Michalski, H.M. Sandler, L. Northouse, L. Hembroff, X. Lin, T.K. Greenfield, M.S. Litwin, and C.S. Saigal Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med. 358 2008 1250 1261
3. J.A. Talcott, J. Manola, J.A. Clark, I. Kaplan, C.J. Beard, S.P. Mitchell, R.C. Chen, M.P. O'Leary, P.W. Kantoff, and A.V. D'Amico Time course and predictors of symptoms after primary prostate cancer therapy J Clin Oncol. 21 2003 3979 3986
4. B.K. Hollenbeck, R.L. Dunn, J.T. Wei, P.W. McLaughlin, M. Han, and M.G. Sanda Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy Urology 59 2002 480 484
5. N.N. Stone, and R.G. Stock Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years Urology 69 2007 338 342
6. M. Pinkawa, K. Fischedick, M.D. Piroth, B. Gagel, H. Borchers, G. Jakse, and M.J. Eble Prostate-specific antigen kinetics after brachytherapy or external beam radiotherapy and neoadjuvant hormonal therapy Urology 69 2007 129 133
7. M. Pinkawa, K. Fischedick, B. Gagel, M.D. Piroth, H. Borchers, G. Jakse, and M.J. Eble Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer Urology 68 2006 104 109
8. G.S. Merrick, W.M. Butler, K.E. Wallner, B.C. Murray, Z. Allen, and R.W. Galbreath Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy Int J Radiat Oncol Biol Phys. 58 2004 68 74
9. J. Crook, M. McLean, C. Catton, I. Yeung, J. Tsihlias, and M. Pintilie Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation Int J Radiat Oncol Biol Phys. 52 2002 453 460
10. L. Potters, T. Torre, P.A. Fearn, S.A. Leibel, and M.W. Kattan Potency after permanent prostate brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys. 50 2001 1235 1242
11. F. Mols, P. Stijns, B. Dankaart, S. Houterman, A. Vingerhoets, and A. Hendrikx Health-related quality of life in I-125 prostate brachytherapy patients treated with and without volume-reducing hormone therapy: results of a short-term prospective study J Endourol. 23 2009 153 159
12. L.V. van de Poll-Franse, L. Kwan, R.E. Reiter, S.P. Lee, and M.S. Litwin The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup study J Urol. 2008 1362 1367 179; discussion 1367
13. M. Extermann Measuring comorbidity in older cancer patients Eur J Cancer 36 2000 453 471
14. V. de Groot, H. Beckerman, G.J. Lankhorst, and L.M. Bouter How to measure comorbidity A critical review of available methods J Clin Epidemiol. 56 2003 221 229
15. J.E. Fowler Jr., F.L. Terrell, and D.L. Renfroe Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy J Urol. 156 1996 1714 1718
16. W.H. Hall, R. Ramachandran, S. Narayan, A.B. Jani, and S. Vijayakumar An electronic application for rapidly calculating Charlson comorbidity score BMC Cancer 4 2004 94
17. G. Borghede, and M. Sullivan Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 Qual Life Res. 5 1996 212 222
18. M.J. Barry, F.J. Fowler Jr., M.P. O'Leary, R.C. Bruskewitz, H.L. Holtgrewe, W.K. Mebust, and A.T. Cockett The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol. 1992 1549 1557 148; discussion 1564
19. D.Y. Gelblum, L. Potters, R. Ashley, R. Waldbaum, X.H. Wang, and S. Leibel Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys. 45 1999 59 67
20. G. van Andel, A. Bottomley, S.D. Fossa, F. Efficace, C. Coens, S. Guerif, H. Kynaston, P. Gontero, G. Thalmann, and A. Akdas An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer Eur J Cancer 44 2008 2418 2424
21. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst. 85 1993 365 376
22. D. Osoba, G. Rodrigues, J. Myles, B. Zee, and J. Pater Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol. 16 1998 139 144
23. M.P. Van Gellekom, M.A. Moerland, M. Van Vulpen, H.K. Wijrdeman, and J.J. Battermann Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry Int J Radiat Oncol Biol Phys. 63 2005 772 780
24. G.S. Merrick, W.M. Butler, K.E. Wallner, Z.A. Allen, J.H. Lief, A. Hinerman-Mulroy, and R.W. Galbreath The impact of prostate volume and neoadjuvant androgen-deprivation therapy on urinary function following prostate brachytherapy Cancer J 10 2004 181 189
25. J. Crook, A. Toi, M. McLean, and G. Pond The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy Brachytherapy 1 2002 131 137
26. J. Locke, W. Ellis, K. Wallner, W. Cavanagh, and J. Blasko Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study Int J Radiat Oncol Biol Phys. 52 2002 712 719
27. S.K. Kang, R.H. Chou, R.K. Dodge, R.W. Clough, H.L. Kang, M.G. Bowen, B.A. Steffey, S.K. Das, S.M. Zhou, and A.W. Whitehurst Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method Int J Radiat Oncol Biol Phys. 50 2001 937 945
28. S.A. Arredondo, E.P. Elkin, P.L. Marr, D.M. Latini, J. DuChane, M.S. Litwin, and P.R. Carroll Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE Urology 67 2006 559 565
29. D.M. Latini, J.M. Chan, J.E. Cowan, S.A. Arredondo, C.J. Kane, D.F. Penson, J. DuChane, and P.R. Carroll Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE Urology 68 2006 1242 1247
30. F. Mols, A.E. Aquarius, M.L. Essink-Bot, N.K. Aaronson, P.J. Kil, and L.V. van de Poll-Franse Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study BJU Int. 102 2008 1594 1600